tirzepatide ruling january 2025 Impact of the CVS GLP-1 formulary change: Trends in prescribing Compounded Tirzepatide: Legal & Safe

They help regulate appetite, blood sugar, and metabolic signaling rather than forcing weight loss through stimulation or appetite suppression alone

The best tirzepatide diet plan focuses on protein-first meals, simple, whole foods, and smaller portions eaten slowly

Microdose tirzepatide may be a good fit for patients who want a gentle dual-pathway option, are concerned about side effects, have previously experienced nausea on GLP-1 medications, or want gradual weight management support

Side-by-side compound comparison Receptor targets Tirzepatide GLP-1 + GIP (dual) Semaglutide GLP-1 only Retatrutide GLP-1 + GIP + Glucagon (triple) Half-life Tirzepatide ~5 days Semaglutide ~7 days Retatrutide ~6 days Dosing frequency Tirzepatide Once weekly Semaglutide Once weekly Retatrutide Once weekly Max studied dose Tirzepatide 15 mg / week Semaglutide 2.4 mg / week (Wegovy) Retatrutide 12 mg / week Peak weight loss Tirzepatide 22.5% (SURMOUNT-1, 72 wk) Semaglutide 15.8% (STEP-1, 68 wk) Retatrutide 24.2% (Phase 2, 48 wk) FDA status (June 2026) Tirzepatide Approved (T2D, obesity, OSA) Semaglutide Approved (T2D, obesity, CV risk) Retatrutide Investigational Phase 3 Head-to-head Tirzepatide 20.2% vs semaglutide 13.7% (SURMOUNT-5) Semaglutide Retatrutide Not yet head-to-head vs tirzepatide HFpEF benefit Tirzepatide Yes (SUMMIT, HR 0.62) Semaglutide Yes (STEP-HFpEF) Retatrutide Not yet studied Unique advantage Tirzepatide Best-in-class FDA-approved efficacy

Reading your insulin syringe correctly Standard U-100 insulin syringes come in three sizes: 0.3 mL (30 units) with markings every 0.5 units

The mechanical stimulus of lifting weights sends a signal to your muscles that they are needed